Trial Profile
Study of the relationship between antiemetic effect of aprepitrant and genetic polymorphism of ABC transporter
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2020
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 16 Feb 2011 New trial record